Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01055184 · ClinicalTrials.gov registry record · Phase 1
Effects of Age on Response to the 2009 H1N1 Virus Vaccine
A Phase 1 study, sponsored by University of Rochester.
- Completed
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT01055184 is a Phase 1 study that has completed, run by University of Rochester. The registered enrollment target is 34 participants.
The verdict
NCT01055184, a Phase 1 study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
Unlike most influenza viruses, the 2009 H1N1 virus has affected people between 5 and 40 years old more often than people 60 years old or older. It may be that older people have had greater exposure to previous strains of H1N1 influenza, and this previous exposure protects them from infection. This study will examine how older people respond to a version of the H1N1 virus vaccine that includes a live, noninfectious version of the virus.
Interventions
- BIOLOGICAL 2009 H1N1 Virus Vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2010-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01055184
The ClinicalTrials.gov registry entry for NCT01055184 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 2009 H1N1 Virus Vaccine is the first listed.
NCT01055184 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01055184 about?
NCT01055184 is a clinical study titled "Effects of Age on Response to the 2009 H1N1 Virus Vaccine". Unlike most influenza viruses, the 2009 H1N1 virus has affected people between 5 and 40 years old more often than people 60 years old or older. It may be that older people have had greater exposure to previous strains of H1N1 influenza, and this previous exposure protects them from infection. This s...
What is the current status of trial NCT01055184?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2010-03.
What interventions are being tested in trial NCT01055184?
The interventions under investigation include: 2009 H1N1 Virus Vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT01055184?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.